Free Shipping On Orders Over $100!
Cardiovascular disease does not start with a heart attack.
It develops quietly over years through inflammation, metabolic dysfunction, blood pressure imbalance, and vascular injury.
Our integrative cardiovascular approach focuses on early detection, personalized risk assessment, and long-term prevention.
Most cardiovascular events are preventable when risk is identified early. We focus on detecting problems long before symptoms appear.
Standard cholesterol panels often miss key risk factors. We evaluate particle size, inflammation, insulin resistance, and vascular health.
Not all hypertension is the same. Understanding renin status, vascular tone, and volume balance allows for more precise treatment.
When appropriate, we combine medications, supplements, peptides, nutrition, and lifestyle interventions under medical supervision.
We assess the underlying physiology driving high or low blood pressure rather than treating all cases the same.
Advanced lipid testing helps identify hidden risk even when standard cholesterol appears normal.
Chronic inflammation and endothelial dysfunction are central drivers of cardiovascular disease.
Insulin resistance, visceral fat, and fatty liver disease strongly influence cardiovascular outcomes.
We evaluate markers such as ApoB, small dense LDL, hs-CRP, and other indicators of vascular risk.
Testing such as CIMT and EndoPAT helps assess arterial health before plaque causes symptoms.
Renin and aldosterone testing can help guide more precise hypertension treatment.
DEXA imaging provides objective insight into visceral fat and cardiometabolic risk.
Cardiovascular optimization is often integrated into our metabolic, hormone, and longevity-focused programs.
When appropriate, care plans are coordinated across nutrition, medications, supplements, peptides, and lifestyle strategies to reduce long-term risk.
